Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update – Nasdaq

Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update Nasdaq

GAITHERSBURG, Md., April 01, 2019– Altimmune, Inc., a clinical-stage immunotherapeutics company, today announced financial results for the year.